EB
Insider
Epperly Melissa B,
DirectorEpperly Melissa B, (Director) filed 4 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 4 sales), most often in Roivant Sciences Ltd. (ROIV). The largest single filing was $1.2M of ROIV (41,861 sh × $28.68, as filed), executed Mar 16. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.5M
shares × price, as filed
Last traded
Oct 1
Filed Oct 5
Median ADV $222.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.5M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
ROIVRecent filings
ROIVSALE
Roivant Sciences Ltd.
View filing →
$608K16,850 sh × $36.08
Exec Oct 1
Filed Oct 5 · 6:05 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $172K
4,338 sh × $39.65
Exec Sep 15
Filed Sep 17 · 6:43 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $515K
15,002 sh × $34.32
Exec Jun 29
Filed Jul 1 · 6:34 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $1.2M
41,861 sh × $28.68
Exec Mar 16
Filed Mar 18 · 5:30 PM ET